Atlas Trials

Role of [18F]-FDG Brain PET in Newly Diagnosed Primary Cerebral Lymphoma, in Immunocompetent Patient Older Than 60 Years

Clinical trial NCT03582254 · UNKNOWN

Trial details

NCT number
NCT03582254
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Primary Central Nervous System Lymphoma
Start date
2016-06-13
Primary completion
2021-05-12
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.